Canadian Court Upholds Lipitor In Crystal Form
A federal court in Canada has ruled that Pfizer Inc.'s patent covering the key ingredient in Lipitor would be infringed by Ranbaxy Laboratories Ltd.'s method for developing a generic copy of...To view the full article, register now.
Already a subscriber? Click here to view full article